1. 442TiPA phase I first-in-human, dose-escalation and expansion study to evaluate the safety and tolerability of NUC-3373 in patients with locally advanced, unresectable or metastatic solid malignancies. (23rd October 2018) Authors: Blagden, S; Spiliopoulou, P; Spiers, L; Gnanaranjan, C; Qi, C; Woodcock, V K; Moschandreas, J; Tyrrell, H E J; Griffiths, L; Butcher, C; Ghazaly, E; Evans, T R J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Metabolic syndrome and heart failure: 40 years follow up results of the Seven Countries Study. (3rd October 2022) Authors: Parapid, B; Simic, D V; Stojsic Milosavljevic, A; Ristic, A; Geleijnse, J M; Danchin, N; Blackburn, H; Jacobs, D; Kromhout, D; Adachi, H; Menotti, A; Nissinen, A; Moschandreas, J; Ostojic, M C; Kanjuh, V Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Metabolic syndrome and mortality prediction in the seven countries' study: single or multifactorial. (25th November 2020) Authors: Parapid, B; Danchin, N; Bande, M; Simic, D.V; Kircanski, B; Blackburn, H; Jacobs, D; Menotti, A; Adachi, H; Kromhout, D; Nissinen, A; Moschandreas, J; Nedeljkovic-Arsenovic, O.M.S; Ostojic, M.C; Kanjuh, V Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P-210Cytosponge™ for post‐chemoradiation surveillance of oesophageal cancer: a feasibility study. (2nd July 2019) Authors: Levy, S; Moschandreas, J; Debiram-Beecham, I; O'Donovan, M; Brooks, C; Bailey, A; Hawkins, M; Kadri, S; de Caestecker, J; Crosby, T; Fitzgerald, R; Mukherjee, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗